PPI deprescribing for Encephalopathy
This trial is testing whether proton pump inhibitors increase the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation. Patients will be assessed for symptoms and given tests at two time points. Stool samples will also be collected to allow characterization of the gastrointestinal tract microbiome.
- Liver Encephalopathy
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
How many individuals are receiving care through this clinical trial?
"That is correct. The information available on clinicaltrials.gov points to this study being actively recruiting patients as of now. 40 individuals are needed for the trial which is taking place at a single site."
Are participants still being accepted for this research project?
"Yes, this information can be found on the website clinicaltrials.gov where it is stated that the trial is still recruiting patients."